Alnylam Pharmaceuticals



Ebitda تغيير تاريخ
Acadia Pharmaceuticals USD 12.2M 22.01M 2024-12
Agios Pharmaceuticals USD -123670000 22.2M 2024-12
Alnylam Pharmaceuticals USD -90991000 28.07M 2024-12
Amgen USD 3.71B 265M 2024-12
Arrowhead Research USD -156177000 1M 2024-12
BioMarin Pharmaceutical USD 194.85M 18.43M 2024-12
Incyte USD 320.2M 128.19M 2024-12
Ionis Pharmaceuticals USD -105556000 37.61M 2024-12
Moderna USD -993000000 1.19B 2024-12
Neurocrine Biosciences USD 152.1M 39.2M 2024-12
Novartis USD 6.82B 1.31B 2024-12
PTC Therapeutics USD 1.07M 47.25M 2024-12
Regeneron Pharmaceuticals USD 1.06B 572.8M 2024-12
Sanofi EUR 563M 3.93B 2024-12
Sarepta Therapeutics USD 182.21M 150.21M 2024-12
Takeda JPY 254.6B 125.66B 2024-12
Tectonic Therapeutic USD -13483000 5.73M 2024-12
Ultragenyx Pharmaceutical USD -113199000 10.03M 2024-12
Vertex Pharmaceuticals USD 1.16B 24.5M 2024-12
Xencor USD 7.14M 64.97M 2024-12



Alnylam Pharmaceuticals - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Apr 2025.